Browsing by Author "Hoogerbrugge-van der Linden, N."

Now showing items 1-50 of 223

Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression
Cleophas, M.C.P.; Crisan, T. O.; Kluck, V.; Hoogerbrugge, N. ; Netea-Maier, R.T. ; Dinarello, C.A. ; Netea, M.G. ; Joosten, L.A.B.
2019, Article / Letter to editor (Arthritis Research & Therapy, vol. 21, (2019), article 50)
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype
Grolleman, J.E.; Voer, R.M. de; Elsayed, F.A.; Nielsen, Maartje; Weren, R.D.A.; Palles, Claire; Ligtenberg, M.J.L. ; Vos, J.R.; Kuiper, R.A. ; Kamping, E.J. ; Jansen, E; Jongmans, M.C.J. ; Neveling, K. ; Geurts van Kessel, A. ; Hoogerbrugge, N. ; Kuiper, R.P. et al. sine al.
2019, Article / Letter to editor (Cancer Cell, vol. 35, iss. 2, (2019), pp. 256-+)
De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism
Diets, I.J. ; Donk, R. van der; Baltrunaite, K.; Waanders, E. ; Reijnders, M.R.F. ; Dingemans, A.J.; Pfundt, R.P. ; Vulto-van Silfhout, A.T. ; Wiel, L.J.M. van de; Gilissen, C.F. ; Thevenon, J.; Perrin, L.; Afenjar, A.; Nava, C.; Keren, B.; Bartz, S.; Peri, B.; Beunders, G.; Verbeek, N.; Gassen, K. van; Thiffault, I.; Cadieux-Dion, M.; Huerta-Saenz, L.; Wagner, M.; Konstantopoulou, V.; Vodopiutz, J.; Griese, M.; Boel, A.; Callewaert, B.; Brunner, H.G. ; Kleefstra, T. ; Hoogerbrugge, N. ; Vries, B.B. de ; Hwa, V.; Dauber, A.; Hehir-Kwa, J.Y. ; Kuiper, R.P; Jongmans, M.C.J. et al. sine al.
2019, Article / Letter to editor (American Journal of Human Genetics, vol. 104, iss. 4, (2019), pp. 758-766)
Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome
Sloot, Y.J.E.; Rabold, K.; Netea, M.G. ; Smit, J.W.A. ; Hoogerbrugge, N. ; Netea-Maier, R.T.
2019, Article / Letter to editor (Oncogene, vol. 38, iss. 19, (2019), pp. 3743-3755)
[The relationship between lifestyle and cancer; topic of conversation in the consultation room?]
Swankhuisen, C.E.; Evers, J.; Kiemeney, L.A. ; Hoogerbrugge, N. ; Vegt, F. de
2019, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 163, (2019), article D3344)
[Genetic testing in patients with cancer; new developments]
Ausems, M.G.E.M.; Oosterwijk, J.C. ; Nielsen, M.; Lolkema, M.P.; Hoogerbrugge, N. ; Ligtenberg, M.J.L.
2019, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 163, (2019), article D3801)
TRIM28 haploinsufficiency predisposes to Wilms tumor
Diets, I.J. ; Hoyer, J.; Ekici, A.B.; Popp, B.; Hoogerbrugge, N. ; Reijmersdal, S.V. van ; Bhaskaran, R.; Hadjihannas, M.; Vasileiou, G.; Thiel, C.T.; Seven, D.; Uebe, S.; Ilencikova, D.; Waanders, E.; Mavinkurve-Groothuis, A.M.C. ; Roeleveld, N. ; Krijger, R.R. de; Wegert, J.; Graf, N.; Vokuhl, C.; Agaimy, A.; Gessler, M.; Reis, A.; Kuiper, R.P. ; Jongmans, M.C.J. ; Metzler, M. et al. sine al.
2019, Article / Letter to editor (International Journal of Cancer, vol. 145, iss. 4, (2019), pp. 941-951)
Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling
Hoberg-Vetti, H.; Eide, G.E.; Siglen, E.; Listol, W.; Haavind, M.T.; Hoogerbrugge, N. ; Bjorvatn, C.
2019, Article / Letter to editor (Acta Oncologica, vol. 58, iss. 2, (2019), pp. 175-181)
Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
Vos, J.R.; Giepmans, Lisette; Roehl, Claas; Geverink, N.A.; Hoogerbrugge, N. ; Ligtenberg, M.J. ; Kets, M. ; Peltonen, Sirkku; et al.
2019, Article / Letter to editor (Familial Cancer, vol. 18, iss. 2, (2019), pp. 281-284)
Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial
Vrieling, A.; Visser, A. ; Hoedjes, M.; Hurks, M.; Hoogerbrugge, N. ; Kampman, E.
2018, Article / Letter to editor (Clinical Genetics, vol. 93, iss. 1, (2018), pp. 67-77)
[European Reference Networks for rare diseases]
Vos, J.R.; Zelst-Stams, W.A.G. van; Hoogerbrugge, N.
2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, iss. 0, (2018), article D2376)
The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI
Vreemann, S.; Zelst, J.C.M. van; Schlooz-Vries, M.S. ; Bult, P. ; Hoogerbrugge, N. ; Karssemeijer, N. ; Gubern Merida, A.; Mann, R.M.
2018, Article / Letter to editor (Breast Cancer Research, vol. 20, (2018), article 84)
High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life
Arts-de Jong, M.; Jong, C.A.J. de ; Hermens, R.P.M.G. ; Kissane, D.W.; Massuger, L.F.A.G. ; Hoogerbrugge-van der Linden, N. ; Prins, J.B. ; Hullu, J.A. de
2018, Article / Letter to editor (Journal of Psychosomatic Obstetrics and Gynaecology, vol. 39, iss. 2, (2018), pp. 96-104)
Cancer Risks for PMS2-Associated Lynch Syndrome
Broeke, S.W. ten; Klift, H.M. van der; Tops, Carli M.J.; Aretz, Stefan; Bernstein, I.; Buchanan, Daniel D.; Hoogerbrugge, N. ; Mensenkamp, A.R. ; Spruijt, L. ; Nielsen, M.; Win, Aung Ko et al. sine al.
2018, Article / Letter to editor (Journal of Clinical Oncology, vol. 36, iss. 29, (2018), pp. 2961-2968)
Peritoneal Carcinomatosis After Risk-Reducing Surgery in BRCA1/2 Mutation Carriers
Harmsen, M.G.; Piek, J.M.; Bulten, J. ; Casey, Murray J.; Rebbeck, Timothy R.; Mourits, M.J.; Massuger, L.F.A.G. ; Hoogerbrugge, N. ; Hullu, J.A. de
2018, Article / Letter to editor (Cancer, vol. 124, iss. 5, (2018), pp. 952-959)
Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk
Vreemann, S.; Gubern Merida, A.; Schlooz-Vries, M.S. ; Bult, P. ; Gils, Carla H. van; Hoogerbrugge, N. ; Karssemeijer, N. ; Mann, R.M.
2018, Article / Letter to editor (Radiology, vol. 286, iss. 2, (2018), pp. 443-451)
[Does ovarian cancer start in the fallopian tubes? Possible implications for preventive adnexal removal]
Steenbeek, M.P.; Bulten, J. ; Hoogerbrugge, N. ; Massuger, L.F.A.G. ; Pijnenborg, J.M.A.; Hullu, J.A. de
2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, iss. 0, (2018), article D2337)
A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
Harmsen, M.G.; Steenbeek, M.P.; Hoogerbrugge, N. ; Doorn, H.C. van; Gaarenstroom, K.N.; Vos, M.C.; Massuger, L.F.A.G. ; Hullu, J.A. de ; Hermens, R.P.M.G.
2018, Article / Letter to editor (Health Expectations, vol. 21, iss. 3, (2018), pp. 659-667)
Self-compassion, physical fitness and climacteric symptoms in oophorectomized BRCA1/2 mutation carriers
Arts-de Jong, M.; Westerop, L.L.M. van; Hoogerbrugge, N. ; Massuger, L.F.A.G. ; Maas, A.H.E.M. ; Beek, M.H. van; Hullu, J.A. de
2018, Article / Letter to editor (Maturitas, vol. 108, (2018), pp. 13-17)
Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)
Leenders, E.K.S.M.; Westdorp, H.; Bruggemann, R.J. ; Loeffen, J.; Kratz, C.; Burn, J.; Hoogerbrugge, N. ; Jongmans, M.C.J.
2018, Article / Letter to editor (European Journal of Human Genetics, vol. 26, iss. 10, (2018), pp. 1417-1423)
Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility
Weren, R.D.A.; Post, R.S. van der; Vogelaar, I.P.; Krieken, J.H.J.M. van ; Spruijt, L. ; Lubinski, J.; Jakubowska, A.; Teodorczyk, U.; Aalfs, C.M.; Hest, L.P. van; Oliveira, C. de; Kamping, E.J. ; Schackert, H.K.; Ranzani, G.N.; Garcia, E.B.; Hes, F.J.; Holinski-Feder, E.; Genuardi, M.; Ausems, M.G.E.M.; Sijmons, R.H.; Wagner, A.; Kolk, L.E. van der; Cats, A.; Bjornevoll, I.; Hoogerbrugge, N. ; Ligtenberg, M.J.L. et al. sine al.
2018, Article / Letter to editor (Journal of Medical Genetics, vol. 55, iss. 10, (2018), pp. 669-674)
An online self-test added to colorectal cancer screening can increase the effectiveness of familial cancer risk assessment without increasing distress
Erkelens, A. van; Sie, A.S.; Spanier, M.B.; Kouwen, M.P. van; Visser, A. ; Prins, J.B. ; Hoogerbrugge, N.
2018, Article / Letter to editor (Colorectal Disease, vol. 20, iss. 10, (2018), pp. 897-904)
Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria
Post, R.S. van der; Dieren, Jolanda van; Grelack, A.; Hoogerbrugge, N. ; Kolk, Lizet E. van der; Snaebjornsson, P.; Krieken, J.H. van ; Bisseling, T.M.; Cats, A.
2018, Article / Letter to editor (Gastrointestinal Endoscopy, vol. 87, iss. 2, (2018), pp. 397-+)
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation
Eissing, M.L.L.G.; Ripken, L.S. ; Schreibelt, G. ; Westdorp, H.; Ligtenberg, M.J. ; Netea-Maier, R.T. ; Netea, M.G. ; Vries, I.J.M. de ; Hoogerbrugge, N.
2018, Article / Letter to editor (Translational Oncology, vol. 12, iss. 2, (2018), pp. 361-367)
NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?
Weren, R.D.A.; Ligtenberg, M.J.L. ; Geurts van Kessel, A. ; Voer, R.M. de; Hoogerbrugge, N. ; Kuiper, R.P.
2018, Article / Letter to editor (Journal of Pathology, vol. 244, iss. 2, (2018), pp. 135-142)
High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer
Diets, I.J. ; Waanders, E. ; Ligtenberg, M.J.L. ; Bladel, D.A.G. van ; Kamping, E.J. ; Hoogerbrugge, P.M. ; Hopman, S.; Olderode-Berends, M.J.; Gerkes, E.H.; Koolen, D.A. ; Marcelis, C.L. ; Santen, G.W.E.; Belzen, M.J. van; Mordaunt, D.; McGregor, L.; Thompson, E.; Kattamis, A.; Pastorczak, A.; Mlynarski, W.; Ilencikova, D.; Vulto-van Silfhout, A.T. ; Gardeitchik, T. ; Bont, E.S. de; Loeffen, J.; Wagner, A.; Mensenkamp, A.R. ; Kuiper, R.P. ; Hoogerbrugge, N. ; Jongmans, M.C. et al. sine al.
2018, Article / Letter to editor (Clinical Cancer Research, vol. 24, iss. 7, (2018), pp. 1594-1603)
Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome
Westdorp, H.; Kolders, S.; Hoogerbrugge, N. ; Vries, I.J.M. de ; Jongmans, M.C.J. ; Schreibelt, G.
2017, Article / Letter to editor (Cancer Letters, vol. 403, (2017), pp. 159-164)
Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age
Erkelens, A. van; Derks, L.; Sie, A.S.; Egbers, L.; Woldringh, G.H. ; Prins, J.B. ; Manders, P. ; Hoogerbrugge, N.
2017, Article / Letter to editor (Journal of Genetic Counseling, vol. 26, iss. 4, (2017), pp. 785-791)
Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration
Visser, A. ; Vrieling, A.; Murugesu, L.; Hoogerbrugge, N. ; Kampman, E. ; Hoedjes, M.
2017, Article / Letter to editor (PLoS One, vol. 12, iss. 6, (2017), article e0178205)
Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress
Erkelens, A. van; Sie, A.S.; Manders, P. ; Visser, A. ; Duijm, L.E.M. ; Mann, R.M. ; Voorde, M. Ten; Kroeze, H.; Prins, J.B. ; Hoogerbrugge, N.
2017, Article / Letter to editor (European Journal of Cancer, vol. 78, (2017), pp. 45-52)
Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences
Waanders, E. ; Scheijen, B. ; Jongmans, M.C.J. ; Venselaar, H. ; Reijmersdal, S.V. van ; Dijk, A.H.A. van ; Pastorczak, A.; Weren, R.D.A.; Schoot, C.E. van der; Vorst, J.M. van de; Sonneveld, E.; Hoogerbrugge, N. ; Velden, V.H. van der; Gruhn, B.; Hoogerbrugge, P.M. ; Dongen, J.J. van; Geurts van Kessel, A.H.M. ; Leeuwen, F.N. van ; Kuiper, R.P. et al. sine al.
2017, Article / Letter to editor (Leukemia, vol. 31, iss. 4, (2017), pp. 821-828)
Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas.
Weren, R.D.A.; Mensenkamp, A.R. ; Simons, M.; Eijkelenboom, A.; Sie, A.S.; Ouchene, H.; Asseldonk, M. van; Gomez-Garcia, E.B.; Blok, M.J.; Hullu, J.A. de ; Nelen, M.R. ; Hoischen, A. ; Bulten, J. ; Tops, B.B.J.; Hoogerbrugge, N. ; Ligtenberg, M.J.L. et al. sine al.
2017, Article / Letter to editor (Human Mutation, vol. 38, iss. 2, (2017), pp. 226-235)
Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography
Zelst, J.C.M. van; Mus, R.D.M. ; Woldringh, G.H. ; Rutten, M.; Bult, P. ; Vreemann, S.; Jong, M de; Karssemeijer, N. ; Hoogerbrugge, N. ; Mann, R.M.
2017, Article / Letter to editor (Radiology, vol. 285, iss. 2, (2017), pp. 376-388)
Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing
Vogelaar, I.P.; Post, R.S. van der; Krieken, J.H. van ; Spruijt, L. ; Zelst-Stams, W.A.G. van; Kets, C.M. ; Lubinski, J.; Jakubowska, A.; Teodorczyk, U.; Aalfs, C.M.; Hest, L.P. van; Pinheiro, H.; Oliveira, C. de; Jhangiani, S.N.; Muzny, D.M.; Gibbs, R.A.; Lupski, J.R.; Ligt, J. de ; Vissers, L.E.L.M. ; Hoischen, A. ; Gilissen, C. ; Vorst, J.M. van de; Goeman, J.J. ; Schackert, H.K.; Ranzani, G.N.; Molinaro, V.; Garcia, E.B.; Hes, F.J.; Holinski-Feder, E.; Genuardi, M.; Ausems, M.; Sijmons, R.H.; Wagner, A.; Kolk, L.E. van der; Bjornevoll, I.; Hoberg-Vetti, H.; Geurts van Kessel, A.H.M. ; Kuiper, R.P. ; Ligtenberg, M.J.L. ; Hoogerbrugge, N. et al. sine al.
2017, Article / Letter to editor (European Journal of Human Genetics, vol. 25, iss. 11, (2017), pp. 1246-1252)
A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.
Zhang, J.; Wang, W.; Voer, R.M. de; Hehir-Kwa, J.Y. ; Kamping, E.J. ; Weren, R.D.A.; Nelen, M.; Hoischen, A. ; Ligtenberg, M.J.L. ; Hoogerbrugge, N. ; Yang, X; Yang, Z; Fan, X.; Wang, L.; Liu, H.; Wang, J; Kuiper, R.P. ; Geurts van Kessel, A.H.M. et al. sine al.
2017, Article / Letter to editor (Oncotarget, vol. 8, (2017), pp. 24533-24547)
Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition
Diets, I.J. ; Nagtegaal, I.D. ; Loeffen, J.; Blaauw, I. de ; Waanders, E. ; Hoogerbrugge, N. ; Jongmans, M.C.J.
2017, Article / Letter to editor (British Journal of Cancer, vol. 116, iss. 2, (2017), pp. 163-168)
Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease
Derikx, L.A.A.P.; Smits, L.J.T. ; Lent-van Vliet, S. van; Dekker, E.; Aalfs, C.M.; Kouwen, M.C.A. van ; Nagengast, F.M. ; Nagtegaal, I.D. ; Hoogerbrugge, N. ; Hoentjen, F.
2017, Article / Letter to editor (Clinical Gastroenterology and Hepatology, vol. 15, iss. 3, (2017), pp. 454-458.e1)
High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling
Sie, A.S.; Spruijt, L. ; Zelst-Stams, W.A.G. van; Mensenkamp, A.R. ; Ligtenberg, M.J.L. ; Brunner, H.G. ; Prins, J.B. ; Hoogerbrugge, N.
2016, Article / Letter to editor (Journal of Genetic Counseling, vol. 25, iss. 3, (2016), pp. 504-514)
Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline
Os, N.J.H. van; Roeleveld, N. ; Weemaes, C.M. ; Jongmans, M.C. ; Janssens, G.O.; Taylor, A.M.; Hoogerbrugge, N. ; Willemsen, M.A.
2016, Article / Letter to editor (Clinical Genetics, vol. 90, iss. 2, (2016), pp. 105-117)
Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers
Ghorbanoghli, Z.; Nieuwenhuis, M.H.; Houwing-Duistermaat, J.J.; Jagmohan-Changur, S.; Hes, F.J.; Tops, C.M.; Wagner, A.; Aalfs, C.M.; Verhoef, S.; Gomez Garcia, E.B.; Sijmons, R.H.; Menko, F.H.; Letteboer, T.G.; Hoogerbrugge, N. ; Wezel, T. van; Vasen, H.F.; Wijnen, J.T. et al. sine al.
2016, Article / Letter to editor (Familial Cancer, vol. 15, iss. 4, (2016), pp. 563-570)
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers
Suerink, M.; Klift, H.M. van der; Broeke, S.W. ten; Dekkers, O.M.; Bernstein, I.; Capella Munar, G.; Garcia, E.; Hoogerbrugge, N. ; Letteboer, T.G.; Menko, F.H.; Lindblom, A.; Mensenkamp, A.; Moller, P.; Os, T.A. van; Rahner, N.; Redeker, B.J.; Olderode-Berends, M.J.; Spruijt, L. ; Vos, Y.J.; Wagner, A.; Morreau, H.; Hes, F.J.; Vasen, H.F.A.; Tops, C.M.; Wijnen, J.T.; Nielsen, M. et al. sine al.
2016, Article / Letter to editor (Genetics in Medicine, vol. 18, iss. 4, (2016), pp. 405-409)
Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial
Visser, A. ; Laarhoven, H.W. van ; Woldringh, G.H. ; Hoogerbrugge, N. ; Prins, J.B.
2016, Article / Letter to editor (Acta Oncologica, vol. 55, iss. 2, (2016), pp. 178-187)
Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool
Jongmans, M.C. ; Loeffen, J.L.C.M. ; Waanders, E. ; Hoogerbrugge, P.M. ; Ligtenberg, M.J. ; Kuiper, R.P. ; Hoogerbrugge, N.
2016, Article / Letter to editor (European Journal of Medical Genetics, vol. 59, iss. 3, (2016), pp. 116-125)
Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research
Burbach, J.P.H.; Kurk, S.A.; Cpebergh van den Braak, R.R.; Dik, V.K.; May, A.M.; Meijer, G.A.; Punt, C.J.A. ; Vink, G.R.; Los, M.; Hoogerbrugge, N. ; Huijgens, P.C.; Ijzermans, J.N.; Kuipers, E.J.; Noo, M.E. de; Pennings, J.P.; Velden, A.M. van der; Verhoef, C.; Siersema, P.D.; Oijen, M.G. van; Verkooijen, H.M.; Koopman, M. et al. sine al.
2016, Article / Letter to editor (Acta Oncologica, vol. 55, iss. 11, (2016), pp. 1273-1280)
Opportunities for immunotherapy in microsatellite instable colorectal cancer
Westdorp, H.; Fennemann, F.L.; Weren, R.D.A.; Bisseling, T.M.; Ligtenberg, M.J. ; Figdor, C.G. ; Schreibelt, G. ; Hoogerbrugge, N. ; Wimmers, F.; Vries, I.J.M. de
2016, Article / Letter to editor (Cancer Immunology Immunotherapy, vol. 65, iss. 10, (2016), pp. 1249-1259)
Cardiovascular risk of BRCA1/2 mutation carriers: A review
Westerop, L.L.M. van; Arts-de Jong, M.; Hoogerbrugge, N. ; Hullu, J.A. de ; Maas, A.H.E.M.
2016, Article / Letter to editor (Maturitas, vol. 91, (2016), pp. 135-139)
Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk
Harmsen, M.G.; Hout, J. in't; Jong, M. de; Hoogerbrugge, N. ; Massuger, L.F.A.G. ; Hermens, R.P.M.G. ; Hullu, J.A. de
2016, Article / Letter to editor (Obstetrics and Gynecology, vol. 127, iss. 6, (2016), pp. 1054-1063)
Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience
Harmsen, M.G.; Jong, M. de; Horstik, K.; Manders, P. ; Massuger, L.F.A.G. ; Hermens, R.P.M.G. ; Hoogerbrugge, N. ; Woldringh, G.H. ; Hullu, J.A. de
2016, Article / Letter to editor (Gynecologic Oncology, vol. 143, iss. 1, (2016), pp. 113-119)
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
Hoberg-Vetti, H.; Bjorvatn, C.; Fiane, B.E.; Aas, T.; Woie, K.; Espelid, H.; Rusken, T.; Eikesdal, H.P.; Listol, W.; Haavind, M.T.; Knappskog, P.M.; Haukanes, B.I.; Steen, V.M.; Hoogerbrugge, N. et al. sine al.
2016, Article / Letter to editor (European Journal of Human Genetics, vol. 24, iss. 6, (2016), pp. 881-888)
Finding all BRCA pathogenic mutation carriers: best practice models
Hoogerbrugge, N. ; Jongmans, M.C.
2016, Article / Letter to editor (European Journal of Human Genetics, vol. 24 Suppl 1, (2016), pp. S19-26)

Now showing items 1-50 of 223

Search Repository

Browse

All of Repository

Radboud Repository

Browsing by Author "Hoogerbrugge-van der Linden, N."

Search Repository

Browse

All of Repository